1. Home
  2. TRNS vs AMPH Comparison

TRNS vs AMPH Comparison

Compare TRNS & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transcat Inc.

TRNS

Transcat Inc.

HOLD

Current Price

$88.86

Market Cap

861.5M

Sector

Industrials

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$19.79

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRNS
AMPH
Founded
1964
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
861.5M
971.8M
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
TRNS
AMPH
Price
$88.86
$19.79
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$116.00
$28.38
AVG Volume (30 Days)
178.4K
587.4K
Earning Date
05-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.57
0.14
Revenue
$331,877,000.00
$719,887,000.00
Revenue This Year
$21.75
$6.90
Revenue Next Year
$7.55
$4.64
P/E Ratio
$156.19
$140.29
Revenue Growth
19.20
N/A
52 Week Low
$50.23
$16.65
52 Week High
$94.76
$31.26

Technical Indicators

Market Signals
Indicator
TRNS
AMPH
Relative Strength Index (RSI) 51.54 48.29
Support Level $86.10 $18.57
Resistance Level $94.48 $20.13
Average True Range (ATR) 3.75 0.95
MACD -0.58 0.03
Stochastic Oscillator 28.98 37.57

Price Performance

Historical Comparison
TRNS
AMPH

About TRNS Transcat Inc.

Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: